Over half of patients treated with combination therapy were alive and relapse-free after five years

AZ will take the programme forward into clinical development

Middle dose tested hit the primary endpoint of the Phase II trial

Employee safety is patient safety – this becomes clearer than ever during the Corona pandemic. It is not […]

People with sleep condition could be at an increased risk of adverse outcomes from COVID-19

Researchers found combination treatment showed promise against a range of cancer types

Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy

World Evidence-based Healthcare Day takes place on 20 October

Updated Date: Wed, 09 Sep 2020 00:00:00 EDT

Updated Date: Wed, 09 Sep 2020 00:00:00 EDT